Search results
Results from the WOW.Com Content Network
Polyestradiol phosphate (PEP), sold under the brand name Estradurin, is an estrogen medication which is used primarily in the treatment of prostate cancer in men. [1] [9] [2] [10] It is also used in women to treat breast cancer, as a component of hormone therapy to treat low estrogen levels and menopausal symptoms, and as a component of feminizing hormone therapy for transgender women.
Estrogen is the predominant sex hormone that slows bone loss (even in men). Both estrogen and testosterone help stimulate bone formation (T, especially at puberty). Testosterone may cause an increase in cortical bone thickness in transgender men (however this does not necessarily translate to a greater mechanical stability).
[50] [17] [28] [47] These men were age 51 to 84 years (mean 68 years), and men with pre-existing cardiovascular disease were excluded. [ 12 ] [ 17 ] [ 51 ] A considerable incidence of cardiovascular complications was reported for the estradiol undecylate group (76%; 16/21 incidence total); there was a 67% (14/21) incidence of cardiovascular ...
Ethinylestradiol sulfonate (EES), sold under the brand names Deposiston and Turisteron among others, is an estrogen medication which has been used in birth control pills for women and in the treatment of prostate cancer in men. [1] [5] [2] [3] [6] It has also been investigated in the treatment of breast cancer in women.
Certain chemotherapies, steroids, hormonal medications like anti-estrogen treatments, antidepressants, or antipsychotics are known to cause weight gain. This means you may not see as much weight ...
Men and women exhibit different symptoms for hypergonadism. A few of the symptoms that men can experience are increased sex drive, early balding, excessive muscle mass, and acne. Women can have symptoms such as, increased growth of facial hair, deepened voice, coarse body hair, and an irregular menstrual cycle. [5]
An online survey conducted by the Cleveland Clinic of 1,174 men 18 years or older, found that 72% of men would rather do household tasks, such as cleaning the bathroom or mowing the lawn, than see ...
The prevalence of gynecomastia in men may have increased in recent years, but the epidemiology of the disorder is not fully understood. [40] The use of anabolic steroids and exposure to chemicals that mimic estrogen in cosmetic products, organochlorine pesticides , and industrial chemicals have been suggested as possible factors driving this ...